Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield healthcare technology company, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its 24th issued US patent. This new patent expands Aclarion’s proprietary rights to utilize magnetic resonance spectroscopy (MRS) to measure propionic acid (PA) as a biomarker for identifying potential…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here